Home RxNorm 1991509 citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML Oral Solution [Clenpiq] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1991509
RxNorm name citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML Oral Solution [Clenpiq]
Display name CLENPIQ (Oral Liquid)
Full name citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML Oral Solution [Clenpiq]
Term type SBD
Status Active
Strength 75-21.9-0.0625 mg/ml
Dose form Sol
Route Oral Liquid
Updated 2026-11-14 08:32:27 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 012018
Active start 012018
Multiple ingredient YES
Branded YES
Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength picosulfate sodium 0.0625 MG / 1 ML picosulfurate picosulfate sodium citric acid 75 MG / 1 ML citric acid citric acid magnesium oxide 21.9 MG / 1 ML magnesium oxide magnesium cation
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.
NDC11, Source, Active table NDC11 Source Active 55566670000 rxnav_ndcs yes 55566670002 rxnav_ndcs yes 55566670001 rxnav_historical 72032670000 rxnav_historical 72032670001 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective ea24a07b-34ca-4da4-ba69-73bbf44de20d These highlights do not include all the information needed to use CLENPIQ ® safely and effectively. See full prescribing information for CLENPIQ. CLENPIQ ® (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution Initial U.S. Approval: 2012 Ferring Pharmaceuticals Inc. | ASM Aerosol-Service AG | Ferring Production Inc. | Jungbunzlauer Ladenburg GmbH | Cambrex Profarmaco Milano S.R.L. | Tomita Phamaceutical Co., Ltd. | F.M. Howell & Company 20201026 a40a02ad-93ca-4658-b413-eb4017917034 These highlights do not include all the information needed to use CLENPIQ™ safely and effectively. See full prescribing information for CLENPIQ. CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution Initial U.S. Approval: 2012 ASM Aerosol-Service AG | Interlabor 20200120
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 75 MG/ML / 21.9 MG/ML / 0.0625 MG/ML (expressed as picosulfate sodium) ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US NAMES Prescribable Synonym CLENPIQ 10 MG / 3.5 GM / 12 GM in 160 mL Oral Solution SOURCES Source Gold Standard Alchemy